Sernova (TSE:SVA) has released an update.
Sernova Corp., a biotech firm engaged in developing cell therapies for chronic diseases, has announced Jonathan Rigby as its new CEO. Rigby, who has a successful track record in raising capital and leading biotech companies to strategic acquisitions, is committed to advancing Sernova’s mission, particularly its leading project, the Cell Pouch System for a ‘functional cure’ in type 1 diabetes.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
